“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The U.S. Food and Drug Administration (FDA) issued a new guidance, entitled Electronic Submission Template for Medical Device 510(k) Submissions. 510(k) electronic submission requirements will…
The U.S. Food and Drug Administration (FDA) issued a new draft guidance, entitled Ethical Considerations for Clinical Investigations of Medical Products Involving Children. As a…
Season 1 – Episode 18: Accommodations in Online Learning The Americans with Disabilities Act (ADA) aims to make education more accessible for individuals with disabilities…
The National Institutes of Health (NIH) has released two new documents providing supplemental information to the NIH Policy for Data Management and Sharing (DMS). They…
Since the Health Insurance Portability and Accountability Act (HIPAA) was signed into law in 1996, federal and state agencies have developed and refined privacy rules…
The Council on Governmental Relations (COGR) has released version two of their research security comparison chart, summarizing and comparing federal laws, regulations, and policies. The…
The President of United States of America has issued an executive order to promote a sustainable, safe, and secure bioeconomy. Thirteen sections detail a wide-range…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
The National Security Presidential Memorandum 33 (NSPM-33) is an increasingly discussed topic in academia. The National Science and Technology Council’s (NTSC) Implementation Guide highlights four…
The U.S. Food and Drug Administration (FDA) issued an update guidance, titled Compounding Animal Drugs from Bulk Drug Substances. This guidance is a continuation of…
